Advances in research on personalized venous thromboembolism risk assessment tools
2022-09-29
来源:汇智旅游网
Chinese Nursing Research 3(2016)113-116 Contents Iists available at SeienceDirect Chinese Nursing Research jou rnaI hemepage:http://www.journaIs.elsevier.core/chinese-nu rsing。resea rch A R T I C L E I N F 0 ^rdcle history: Received 8 October 2015 Received in revised form 15 Ianuary 2016 A B S T R A C T This paper describes the definition of venous thromboembolism and introduces to personalized venous thromboembolism risk assessment tools overseas.Thoughts are given on the development,amendment, application and validation of these tools.The paper provides a reference for building personalized venous thromboembolism risk assessment tools in China. @2016 Shanxi Medica1 Periodical Press.Publishing services by Elsevier B.V.This is an open access article Accepted 17 Iune 2016 Available online 15 September 2016 under the CC BY-NC—ND license(http://creativecommons.0rg『licenses/bv—nc—nd/4.o/). Keywords: Venous thromboembolism Deep vein thrombosis Pulmonary embolism Risk assessment scale Risk assessment model in a deep vein that blocks the lumen and results in venous reflux The incidence of venous thromboembolism fVTE)is up to 0.0816%in the United States. and the incidence of、厂rE is also increasing each year in Asian populations. VTE has become a public issue that seriously threatens human health and economic development. It is therefore critica1 to timely perform、厂rE risk assessment and undertake、厂rE prevention in patients. Relevant guidelines0t suggest that it is necessan,to use、厂rE risk assessment disorder. Typical symptoms of DVT include swelling.pain.and even ulcers in the affected limbs.1f thrombi detach and reach the lungs through the circulation。they may block pulmonary arteries and result in PE.PEs manifest as chest pain.dyspnea.and even sudden death.This condition is extremely harmfu1.and 25%of DVT patients SOfief ffom sudden death due to PE. models fRAMs)for、厂rE risk assessment and stratiifcation in pa— tients and to take appropriate preventive measures to reduce the incidence of、厂rE.There are numerous studies on、厂rE RAMs 0ver- 3.Personalized、厂l risk assessment tools overseas 3.I.Caprini RAM seas.but such research efforts still lack a systematic and effective system in China.This paper reviews the current state of the science and advances in research on personalized、厂rE RAMs overseas to In the 1ate 1980s.Ioseph et al from the United States designed the Caprini、厂rE RAM based on clinical experience and the results of existing studies.The Caprini RAM.which has been translated and published in 12 languages.‘ ・“includes approximately 40 risk fac— tots.Each factor is given a score of 1—5 points by which the risk of provide a Feference for building personalized、厂rE RAMs in China. 2.Definition of、,1lE 、厂rE f0F patients is ranked into foUF grades:low risk f<3 points), Ⅵ.E includes deep vein thrombosis(DVT)and pulmonary thromboembolism(PE).DVT refers to abnormal blood coagulation moderate risk(3-4 points),high risk(5-8 points),and extremely high risk f>8 points);appropriate preventive measures and dura— tion of therapy are recommended accordingly.Large—sample C0rresp0nding author. retrospective studies demonstrated the feasibility and effective— ness of the Caprini RAM f0r preventing VTE in patients. 一14 In China,retrospective and prospective studies have also shown that this mode1 is an effective too1 to screen high—risk populations for E—mail address:linmei561020@163.corn(M.Lin). Peer review under responsibility of Shanxi Medical Periodical Press http://dx.doi.org/10.1016 ̄.cnre.2016.06.013 2095—7718/ ̄2016 Shanxi Medical Periodical Press.Publishing services by Elsevier B.V.This is an open access article under the CC BY-NC—ND license fhttp://creativecommons. 0rg/licenses/by—nc—nd/4.o/). 116 C—L Wu et a1. Chinese Nursing Research 3(2016)113—116 1 2.Bah1 V.Hu HM,Henke PK.Wakefield .Campbell Ir DA,Caprini lA. A validation study of a retrospective venous thromboembolism risk scoring method.Ann Surg.201 0:251:344—350 13 Pannucci Cl1 Bailey SH,Dreszer G,et a1.Validation of the Caprini risk assess— ment model in plastic and recOnstructive surgery patients.,^m Coll Surg. 2011:212:105—112. 14.Shuman AG.Hu HM,Pannucci CJ,Iackson CR,Bradford CR.Bahl V.Stratifying the risk of venous thromboembolism in otolaryngology.Otolaryngof Head Neck Surg.2012:146:719—724. 1 5.Zhou H,Wang L.Wu X.et a1.Validation of a venous thromboembolism risk assessment model in hospitalized Chinese patients:a case—control study. f^theroscler Thromb.2014:21:261-272. 16 Autar R.Nursing assessment of clients at risk of deep vein thrombosis fDVT): the Autar DVT scale.,Adv Nurs.1996;23:763-770. 1 7.Autar R.The management of deep vein thrombosis:the Autar DVT risk assessment scale re—visited.,Orthop Nurs.2003:7:1 14—124. 18.Bfiyrikyllmaz F.Sendir M.Autar R.Yazgan I_Risk level analysis for deep vein thrombosis(DVT):a study of Turkish patients undergoing major orthopedic surgery.f Vasc Nurs.2015:33:100—105. 19.Greenfield Ll lProctor MC,Rodriguez IL,Luchette FA,Cipolle MD,Cho I.Post— trauma thromboembolism prophylaxis.,Trauma.1997;42:100-1O3. 20.Hegsted D,Gritsiouk Y,Schlesinger P.Gardiner S,Gubler KD.Utility of the risk assessment profile for risk stratiifcation of venous thrombotic events for trauma patients.Am,Surg.2013;205:517—520. 21.Acuria DL,Berg GM.Harrison BL.Wray T.Dorsch D,Sook C.Assessing the use of venous thromboembolism risk assessment profiles in the trauma population:is it necessary?Am Surg.201 1:77:783—789. 22.Kucher N.Koo S,Quiroz R.et a1.Electronic alerts t0 prevent venous throm— boembolism among hospitalized patients N Engl,MPd.2005;352:969—977. 23.Barbar S.Noventa F.Rossetto V.et a1.A risk assessment mode1 for the iden— tiifcation of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score.f rhromb Haemost.2010:8:2450—2457. 24.Vardj M,Ghanem—Zoubi N0,Zidan R,Yurin V,Bitterman H.Venous throm— boembolism and the utility of the Padua prediction score in patients with sepsis admitted to internal medicine departments., romb Haemost.2013;1 1: 467—473. 25.Kahn SR.Lim W,Dunn AS.et a1.Prevention 0f ̄厂rE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis,9th ed:American col— lege of chest physicians evidence—based clinical practice guidelines.Chest. 2012:141:el958-e2268. 26.Spyropoulos AC.Anderson Jr FA,Fitzgerald G,et a1.Predictive and associative models to identi~hospitalized medical patients at risk for ̄rrE.Chest. 2011:140:706-714. 27.Tapson VF.Decousus H,Pini M,et a1.Venous thromboembolism prophylaxis in acutely Il lhospitalized medical patients:findings from the International Medical Prevention Registry on Venous Thromboembolism.Chest.2007;132:936——945. 28.Rosenberg D,Eichorn A,Alarcon M,McCullagh L.McGinn T,Spyropoulos AC. External validation of the risk assessment model of the InternatiOnal Medical Prevention Registyr on Venous Thromboembolism fIMPROVE1 for medical patients in a tertiary health system.,^m№artASSOC.2014;3:eO01152. 29.Woiler SC,Stevens SM,Iones IP,et a1.Derivation and validation of a simple model t0 identi~venous thromboembolism risk in medical patients.Am f Med. 2011:124:947—954.e2. 30.Spyropoulos AC.Anderson FA.The“risk”of risk assessment models for venous thromboembolism in medical patients.Am,Med.2012:125:e23—24. 31.Woiler SC,Stevens SM,Iones IP,et a1.The“risk”of risk assessment models for venous thromboembolism in medical patients reply.Am J Med.2012:125: e25-26. 32.Esmon CT.Basic mechanisms and pathogenesis of venous thrombosis.Blood Rev.2009:23:225—229. 33.Zhang xH,Yu JH,Chu J,Hu Q Research progress and prospect of deep vein thrombosis risk assessment.Chfn Nurs Res.2014;32:3982—3985 fin Chinese). 34.Li YH.Risk factors of ICU patients developed venous thromboembolism and nursing intervention for them.Chin NuFs Res.2009:06:475—477 fin Chinese】. 35 Tang Y,Guo QS,Zhao YF,Chen YQ Chen H.Risk factor analysis of traumatic fractures combined with lower limb deep vein thrombosis.d1fn,n uma. 2010:26:1122—1125 fin Chinese). 36 Xu z、Ⅳ,Wan SY,Ding Y,Pan S Q,Zhang TF.The related research of hypertension and deep venous thrombosis.Chin f Mod Med.201O:20:3485—3487 (in Chinese). 37 Yang YH,Guo XJ,Zhao ZG,et a1.Study on the risk factors regarding deep venous thrombosis in acute pulmonary thromboembolism.[hfn『Epidem. 2008:29:716—719(in Chinese). 38 Li CY Investigation and nursing measures of patients with thrombosis of deep vein in ICU.1nt f Nurs Sci.2007;42:629 631 fin Chinese). 39.Guvatt GH.Eikelboom IW.Gould MK,et a1.Approach to outcome measurement in the prevention of thrombosis in surgical and medicaI patients:antith— rombotic therapy and prevention of thrombosis,9th ed:American college of chest physicians evidence—based clinical practice guidelines.Chest.2012:141: el85S一1948. 40.Decousus H.Tapson VF,Bergmann JF,et a1.Factors at admission associated with bleeding risk in medical patients:findings from the IMPROVE in— vestigators.Chest.201 1;139:69-79. How to cite this article:Wu C—L,Lin M,Bao et a1.Advances in research on personalized venous thromboembolism risk assessment tools.Chin Nurs Res.2016;3:113-116.http:/| dx.doi.org/10.1016/j.cnre.2016.06.013